9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-L1) inhibits T cell activation. PD-L1 expression was detected in different malignancies and associated with poor prognosis. Therapeutic antibodies inhibiting PD-1/PD-L1 interaction have been developed.

          Related collections

          Author and article information

          Journal
          Eur J Cancer
          European journal of cancer (Oxford, England : 1990)
          Elsevier BV
          1879-0852
          0959-8049
          Jun 2013
          : 49
          : 9
          Affiliations
          [1 ] Department of Surgery, University Hospital of Basel, Switzerland; Institute for Surgical Research and Hospital Management ICFS, Department of Biomedicine, University of Basel, Switzerland. Electronic address: rdroeser@uhbs.ch.
          [2 ] Department of Surgery, University Hospital of Basel, Switzerland; Institute for Surgical Research and Hospital Management ICFS, Department of Biomedicine, University of Basel, Switzerland.
          [3 ] Department of Surgery, University Hospital of Basel, Switzerland.
          [4 ] Institute of Pathology, University of Bern, Switzerland.
          [5 ] Institute of Pathology, University of Basel, Switzerland.
          [6 ] Department of Surgery, Ospedale Regionale di Lugano, Switzerland.
          [7 ] Department of Surgery, Kantonsspital Olten, Switzerland.
          [8 ] Institute for Surgical Research and Hospital Management ICFS, Department of Biomedicine, University of Basel, Switzerland.
          [9 ] Institute of Translational Pharmacology, National Council Research, Rome, Italy.
          Article
          S0959-8049(13)00123-8
          10.1016/j.ejca.2013.02.015
          23478000
          0356eff3-bfd7-4e0d-bb0a-b88cbf693d45
          Copyright © 2013 Elsevier Ltd. All rights reserved.
          History

          Comments

          Comment on this article